Applied Therapeutics, Inc.
|Company Name||Applied Therapeutics, Inc.|
On August 17, 2020, Applied Therapeutics revealed that the U.S. Food and Drug Administration had placed a partial clinical hold on the Company’s ACTION-Kids study, citing the need for additional technical information to ensure that each study participant has access to the drug’s benefits. The ACTION-Kids study is evaluating the Company’s AT-007 drug for the treatment of galactosemia.
On this news, the Company’s shares fell $3.53 per share, or 12.07%, to close at $25.71 per share on August 17, 2020.
Submit Your Information
If you suffered a loss on your Applied Therapeutics, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.